Figure 1 | Scientific Reports

Figure 1

From: The paradox of highly effective sofosbuvir-based combination therapy despite slow viral decline: can we still rely on viral kinetics?

Figure 1

Observed viral kinetics and virologic responses in the SYNERGY and SPARE trials. Upper row: observed median viral load versus time during the first week of treatment (left panel) and during 6 weeks of treatment (right panel). Lower row:proportion of data below the limit of quantification (LOQ) and/or the limit of detection (LOD) during treatment. In these trials LOQ = 12 IU/mL and LOD = 3 IU/mL.

Back to article page